Factors determining the clinical outcome of acute variceal bleed in cirrhotic patients

Indian Journal of Gastroenterology

Volumn 28, Issue 3, 2009, Pages 93-95

  Majid, Shahid ^a   Azam, Zahid ^a   Shah, Hasnain Ali ^a   Salih, Mohammad ^a   Hamid, Saeed ^a   Abid, Shahab ^a   Jafri, Wasim ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Diabetes mellitus; Gastric varix; Gastro intestinal hemorrhage; Portal hypertension

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; NOVAPRESSIN; OCTREOTIDE; PROTON PUMP INHIBITOR; TERLIPRESSIN; UNCLASSIFIED DRUG; ENBUCRILATE;

ACUTE DISEASE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; ESOPHAGUS VARICES BLEEDING; HUMAN; INFECTION; LABORATORY DIAGNOSIS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; RADIODIAGNOSIS; RECURRENT DISEASE; RISK FACTOR; SCLEROTHERAPY; STOMACH HEMORRHAGE; STOMACH SURGERY; STOMACH VARICES; TREATMENT FAILURE; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS;

ACUTE DISEASE; DIABETES COMPLICATIONS; ENBUCRILATE; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HEMOSTATIC TECHNIQUES; HUMANS; LIVER CIRRHOSIS; PROGNOSIS; RECURRENCE; SCLEROTHERAPY;

EID: 77449105834     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-009-0034-z     Document Type: Article

References (14)

1. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
2. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004;40:793-801.
3. El Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000;95:3566-73.
4. Imano E, Kanda T, Nakatani Y, et al. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol 1999;31:469-73.
5. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994;20:119-25.
6. Pugliese D, Lee SS, Koshy A, Cerini R, Ozier Y, Lebrec D. Systemic and splanchnic hemodynamic effects of intravenous hypertonic glucose in patients with cirrhosis. Hepatology 1988;8:643-6.
7. Moreau R, Chagneau C, Heller J, et al. Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose. Scand J Gastroenterol 2001;36:303-8.
8. Paquet KJ. Causes and pathomechanisms of oesophageal varices development. Med Sci Monit 2000;6:915-28.
9. Sarin SK, Kumar A. Gastric varices: profile, classification, and management. Am J Gastroenterol 1989;84:1244-9.
10. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
11. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001;49:607-8.
12. El-Zayadi AR, Selim OE, Hamdy H, Dabbous H, Ahdy A, Moniem SA. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998;19:141-4.
13. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004:40:652-9.
14. Abid S, Jafri W, Hamid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebocontrolled trial. Am J Gastroenterol 2009;104:617-23.